ESP Pathology Progress Test 2021 – Updated dates

The European Society of Pathology (ESP) in close collaboration with the UEMS Board of Pathology has announced the 2021 Pathology Progress Test (PPT).  To allow our colleagues a few more days to prepare for the PPT, it has been decided to move the start date to Wednesday, 24 November 2021. The total period of time when the PPT will be available has been exteded by two days, being now available until Friday, 10 December. We would like to take this opportunity to remind the Colleagues who are…

Пълният текст

ESP 2022 EQA Schemes

Invitation for participation The European Society of Pathology (ESP) Foundation is continuing the successful organisation of External Quality Assurance (EQA) Programmes.  We invite colleagues and laboratories interested in Colorectal Carcinomas EQA to register for this Scheme. Registrations are open until 1 February 2022.  More information can be found in the attached flyer.

Пълният текст

3DHISTECH announced the New Diagnostic Package Release.

3DHISTECH is proud to announce the New Diagnostic Package Release. Please find below the latest edition of 3DHISTECH’s Release Newsletter, the official product development update for the New Diagnostic Package Release (including the Track & Sign 2.2 release). 3DHISTECH is proud to announce the New Diagnostic Package Release.  Key features of this package include: •    Ultra-fast Flash Z layer scanning •    New settings panel for Admin user •    User Interface Optimization in CaseManager•    Standardized date pickers – Track&Sign New Diagnostic Product Portfolio…

Пълният текст

IVDR Update

The European Commision (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information among your Colleagues. Please visit the link In Vitro Diagnostic Devices Regulation (europa.eu). Sincerely,European Society of Pathology

Пълният текст

Brain Tumor Diagnosis- Bulgaria

Dear Colleagues,  Molecular diagnosis has indeed become an indissociable part of the neuropathological diagnosis of brain tumors.   Back in 2015 many colleagues kindly participated in our survey on methods available for the neuropathological diagnosis of CNS Tumors. We published the results of the study in Brain Pathology.  https://onlinelibrary.wiley.com/doi/epdf/10.1111/bpa.12383 More recently we have also published an article highlighting the importance of assuring means for performing molecular diagnosis in all countries, richer and poorer, and have pointed out that the WHO classification should…

Пълният текст

Public health: Commission proposes a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation

The European Commission (EC) has proposed a progressive roll-out of the new In Vitro Diagnostic Medical Devices Regulation to prevent disruption in the supply of these essential healthcare products. The ESP would like to draw your attention to this essential press release of EC (14 October 2021) and invite you to disseminate this information to your colleagues and members of the national society. Please visit the link In Vitro Diagnostic Medical Devices Regulation (europa.eu)

Пълният текст

European Society of Pathology Newsletter – Autumn 2021 Edition

We are excited to invite you to read the Autumn 2021 Edition of the European Society of Pathology Newsletter! Find out the latest news concerning ESP, starting with the message from the new ESP President and the new Secretary, the update on the elections and news from the ESP Trainees Subcommittee, as well as presentation of the Polish Society of Pathology. Excited to find out more? Please download your copy of the Autumn 2021 Edition, also directly accessible on our website The…

Пълният текст

Professional automatic solution for large-sized laboratories

Digital Microscopy and AI Clinical and Research Applications West Medica feels strongly that innovation is the key to a brighter future and improves the quality of life for everyone. Development of Vision solutions for digital microscopy is a top priority and the main focus of West Medica. Technology is an increasingly influential factor in many fields as new methods are established every day and that’s the reason why West Medica always tries to be one-step ahead. New analytical procedures are…

Пълният текст